Antibiotics for HIV/AIDS
Antibiotics AIDS Treatment - Antibiotics and HIV/AIDS - AIDS/HIV Antibiotic Resistance
WHO recommends perpetual antibiotics for AIDS
The World Healh Organization has recommended perpetual antibiotics for the treatment of AIDs in Africa. They said it would cost $8 per person per year and greatly increase their life quality. Next thing they are going to recommend it for Lyme? NOT. It has been long since approved for RA by the NIH. What is the problem with Lyme? Maybe the inaccurate lyme test is a blessing? Hey doc, the test says I don't have lyme, so give me the abx, Thanks! My problem was to have "RA" by the book three joints have to be swollen and red. My knees were swollen and ankles were red. Sorry you don't have RA, no abx. Maybe they could get abx approved for IBS? My old doc said you just have IBS now go see a shrink (before you bleed to death). I guess I'm just venting.
Question: Do antibiotics progress Hiv faster in the body or do it help slow Hiv down. If i was newly infected with hiv and taking antibiotics would Hiv show up on a 3 month test?
Answer: Unfortunately Antibiotics have no effect on the actual process of HIV infection or on testing for HIV infection. (Judith Feinberg, MD - University of Cincinnati, College of Medicine)
Antibiotics for AIDS
The administration of an antibiotic to patients newly diagnosed his condition halve mortality in the early stages of the disease, the researchers wrote in an article published in the Lancet medical journal.
The World Health Organization (WHO) and supports this treatment for years, and recommends daily use for the treatment of children with the virus. But experts warn that many people are not given the drug.
Prevention for those affected
Much of the battle of the pharmaceutical against Human Immunodeficiency Virus (HIV) has been focused on the development of antiviral medicines that can extend life expectancy significantly.
You can save tens of thousands of lives with a more extensive use of the drug, which costs a few dollars per day.
However, many patients experiencing the highest risk during the first weeks after diagnosis with multiple infections that threaten their weakened immune system.
Research has estimated that about one quarter of people who are on antiviral therapy programs in sub-Saharan Africa die within the first year of the disease.
But it was discovered that, if these long-term treatment is added the antibiotic cotrimoxazole (Antibiotics for AIDS), can prevent many deaths in people with a defense system most affected.
The Lancet study, conducted in 3179 Ugandan patients showed a reduction of 59% in the first 12 weeks, and 44% between weeks 12 and 72.
But the issue is not so simple, because the drug is not available in many places, say the authors of the study, by scientists from the Medical Research Council Clinical Trials Unit, Imperial College London, and centers in Uganda and Zimbabwe.
Do not forget that there are still millions of people in Africa who need anti-viral and can not get them.
They stated that their findings reinforce the need for swifter action on the part of those responsible for treatment programs.
Professor Charles Gilks, who led the research, said that all the doubts about the effectiveness of the antibiotic and are now well dispelled.
“You can save tens of thousands of lives with a more extensive use of the drug, which costs a few pennies a day,” he said.
To make matters worse, this antibiotic has another benefit: it reduces the incidence of malaria by 25%.
Co-author Diana Gibb said it is necessary to accelerate the availability and supply of the drug and offer it to all new patients in the first 18 months.
But, said Dr. Alvaro Bermejo, head of the International Partnership against HIV/AIDS, access to this treatment is in itself an even bigger problem.
“Let us not forget that there are still millions of people in Africa who need anti-viral and can not get them.
“As the study confirms, antiviral treatment reduces the risk of death in more than 90%, and the antibiotic cotrimoxazole reduces it further.”
Therefore, Dr. Russell stressed the need for concerted efforts to ensure that all who need treatment can get it.
The role of antibiotics in the emergence of AIDS
Chemical antibiotics (e.g. sulphonamides, TMPSMX and Co-trimoxazole), that have been repeatedly administrated from 1970 on in any kind of infections, cause immunosuppression, resistant bacteries and toxic effects like skin rash, nausea and vomiting, leukopenia, pancreatitis, hyperkalemia, thrombo-cytopenia, toxic metabolites, elevated levels of liver enzymes and methhaemoglobinemia. By destroying bacteria in the gut they inhibit the production of immunoglobulins, needed for the body's inner defences, and lay the body open to all sorts of bacterial, fungaland viral infections, including those associated with AIDS. By their strong oxydative effects they lead to a deficiency of glutathionmolecules in cells, that is characteristic for the development of AIDS defining illnesses.
Patients showing this immunodeficiencies induced by the overuse of this antibiotics have been treated from 1985 on with nucleoside analog drugs (e.g. AZT) designed for cancer therapy to induce program-med cell death.
By their cytotoxic effects this substances destroy in the short run various bacteria, fungy and viruses. In the longer run they damage CD-4 and CD-8 helpercells, thereby inducing opportunistic infections such as cytomegalie, toxoplasmosis, herpes simplex, PCP and hepatitis nonAnonB, con-sidered to be characteristic for the AIDS syndrome. By the same effects they damage the DNA in mitochondria resulting in severe irreversiable damages in the brain, the muscles, the bone marrow and internal organs.
Even after 1990 when this effects of nucleoside analog drugs and chemo-antibiotics were approved by animal trials, almost all patients with AIDS defining illnesses and a positive result in HIV-antibody tests were treated with this substances. Their immunodeficiencies and illnesses were traced back to the HIV-retroviruses, which untill today have not been approved to be transmittable viruses according to the established rules in virology. From 1996 on nucleoside anlog drugs were adminstrated together with synthetic protease inhibitors in AIDS patients. As severe damaging effects occured also from this therapy the administration of this cocktails was restricted in 2000 only to patients that show full blown AIDS.
The promotors of the HIV-AIDS-hypothesis, the producers of this substances and the WHO now claim the broad administration of this immunotoxic and cytotoxic substances in the developping countries. They still don't want to investigate the real causes of AIDS defining illnesses and the therapeutic means to restitute immunity in those affected.